Zepbound®
The Eli Lilly branded tirzepatide injector — FDA-approved for chronic weight management and, since December 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity. Prescribed online by US-licensed doctors with insurance verification.
- FDA-approved for chronic weight management (Nov 2023)
- FDA-approved for moderate-to-severe OSA in obesity (Dec 2024)
- Average ~21% body weight reduction at 72 weeks (SURMOUNT-1)
- Insurance billing or LillyDirect cash-pay options
shipping
doctors
doctor 24/7
- Same price at every dose. No hidden fees.
- Free expedited shipping.
- No membership fees.
- Doctor-led plans, ongoing doctor support.
Why do people explore zepbound® therapy?
Lead with chronic weight management — the FDA-approved branded tirzepatide standard.
Weight Loss
- ~21% at 72 weeks
- SURMOUNT-1 trial
- FDA-approved label
Sleep Apnea
- 2024 OSA indication
- SURMOUNT-OASIS data
- AHI improvement
Cardiometabolic
- Lower blood pressure
- Better lipid panel
- Improved A1C
Appetite Control
- Slows digestion
- Reduces cravings
- Dual incretin action
Lose weight with FDA-approved tirzepatide.
Zepbound® is the Eli Lilly pen and vial — same molecule as Mounjaro and compounded tirzepatide, FDA-approved for chronic weight management and now for sleep apnea in obesity.
Zepbound is brand-name tirzepatide manufactured by Eli Lilly and shipped as either a factory-sealed prefilled pen or a single-dose vial. Every unit is dose-standardized and produced under FDA-inspected manufacturing. The active molecule is chemically identical to Mounjaro® and to compounded tirzepatide — what differs is the regulatory pathway, the delivery format, and the FDA-approved indications, which now include both chronic weight management (Nov 2023) and moderate-to-severe obstructive sleep apnea in adults with obesity (Dec 2024).
Your doctor may prescribe Zepbound when you value the FDA approval pathway, qualify for insurance or LillyDirect cash-pay coverage, need the 2024 OSA indication, or prefer the convenience of a branded delivery format. The choice between Zepbound, Mounjaro, and compounded tirzepatide is about access, indication, and clinical fit — part of our broader approach to weight loss.
Complete a quick online health intake
STEP
1
Share your health profile online. A US-licensed doctor reviews your fit and decides whether peptide therapy is right for you.
Receive your prescription at your door
STEP
2
If approved, your custom prescription ships free and overnight in temperature-controlled packaging, arriving safely at your home.
Get continuous care from your doctor
STEP
3
Message your care team anytime for dose adjustments, check-ins, and ongoing support that keeps you progressing toward your goals.
Why choose Peptide12?
Patients pick us for clinical rigor, transparent pricing, and care that doesn’t disappear after checkout.
FDA-registered pharmacies
Every prescription is compounded by FDA-registered 503A/503B pharmacies. Batch testing and certificates of analysis available on request.
US-licensed doctors
MDs licensed in your state, not just an order form. Your doctor titrates dosing and answers messages directly.
Transparent pricing
One flat price per protocol. No membership fees, no insurance hassle, no surprise charges. HSA and FSA accepted. Cancel anytime.
Care that doesn’t disappear
Message your doctor through your patient portal whenever you need to. Most replies within hours, never longer than 24.
What patients say
Real outcomes from people on this protocol, all under doctor supervision.
“Insurance covered Zepbound after the team handled prior auth. Down 41 pounds in eight months on the 10 mg dose and the pen is foolproof.”
Sophia L.
Nashville, TN
“I wanted the FDA-approved branded version specifically. LillyDirect vials at $499 saved me a fortune versus the list price and the doctor walked me through every titration step.”
Anthony R.
Indianapolis, IN
“My pulmonologist wanted me on Zepbound for the new sleep apnea indication. AHI dropped from 38 to 11 over six months and I lost 28 pounds along the way.”
Vanessa K.
Sacramento, CA
“Switched from compounded tirzepatide to Zepbound when my employer added GLP-1 coverage. Same effect, same dose, just FDA-sealed pens. Transition was seamless.”
Christopher M.
Omaha, NE
“Nausea was real for the first three weeks at 2.5 mg but the support team coached me through it. By week twelve I was down two pant sizes and sleeping through the night.”
Jasmine O.
Birmingham, AL
“BMI 36, prediabetic, terrible knees. Zepbound 7.5 mg plus the lifestyle plan has me down 33 pounds, A1C back in normal range, and walking three miles a day.”
Derek H.
Des Moines, IA
Frequently asked questions
Supporting Studies
- 1.Jastreboff et al. — SURMOUNT-1: Tirzepatide Once Weekly for Treatment of Obesity (NEJM, 2022)
- 2.Malhotra et al. — SURMOUNT-OASIS: Tirzepatide for Obstructive Sleep Apnea and Obesity (NEJM, 2024)
- 3.FDA prescribing information — Zepbound® (tirzepatide) injection
- 4.FDA — Compounding and the FDA: Questions and Answers
- 5.NIH MedlinePlus — Tirzepatide Injection